As expected, the non-transgenic animals (WT, SOS1-KO, SOS2-KO) did not develop CML under any circumstances and did not show any alterations in these organs under our experimental conditions. This evidence concerns the gene SOS2 and chronic myelogenous leukemia, BCR-ABL1 positive.